MEDP (Medpace Holdings) Owner Earnings per Share (TTM): 23.89 (As of Jun. 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEDP Medpace Holdings Inc MEDP
97 GF Score
Price $574.99
GF Value $531.14
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Medpace Holdings Owner Earnings per Share (TTM)?

Medpace Holdings MEDP +0.30% 97 Owner Earnings per Share (TTM) is 23.89 as of Jun. 2026, which is 1% above its 10-year median of 23.67. GuruFocus rates MEDP with a GF Score™ of 97/100 and a GF Value™ of $531.14 (Fairly Valued). The stock has 2 warning signs investors should review. Among 75 Medical Diagnostics & Research companies, Medpace Holdings ranks better than 53.33% on this metric.

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Medpace Holdings's Owner Earnings per Share (TTM) ended in Jun. 2026 was $23.89. It's Price-to-Owner-Earnings ratio for today is 24.07.


The historical rank and industry rank for Medpace Holdings's Owner Earnings per Share (TTM) or its related term are showing as below:

MEDP' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 13.25   Med: 23.67   Max: 48.61
Current: 24.11


During the past 13 years, the highest Price-to-Owner-Earnings ratio of Medpace Holdings was 48.61. The lowest was 13.25. And the median was 23.67.


MEDP's Price-to-Owner-Earnings is ranked better than
53.33% of 75 companies
in the Medical Diagnostics & Research industry
Industry Median: 26.46 vs MEDP: 24.11

Medpace Holdings's Earnings per Share (Diluted) for the three months ended in Jun. 2026 was $4.25. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was $17.06. It's PE Ratio (TTM) ratio for today is 33.70.

Medpace Holdings's EPS without NRI for the three months ended in Jun. 2026 was $4.25. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was $17.06. It's PE Ratio without NRI ratio for today is 33.70.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


Medpace Holdings Owner Earnings per Share (TTM) Related Terms


Medpace Holdings Owner Earnings per Share (TTM) Historical Data

* Premium members only.

The historical data trend for Medpace Holdings's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medpace Holdings Owner Earnings per Share (TTM) Chart

Medpace Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.48 10.29 11.67 17.00 21.89

Medpace Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.18 21.94 21.89 23.19 23.89

MEDP vs GH, ICLR, RVTY: Owner Earnings per Share (TTM) Comparison

For the Diagnostics & Research subindustry, Medpace Holdings's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medpace Holdings Price-to-Owner-Earnings vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medpace Holdings's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Medpace Holdings's Price-to-Owner-Earnings falls into.


MEDP
97GF Score
Medpace Holdings Inc MEDP
Owner Earnings per Share (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medpace Holdings Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

Medpace Holdings's Owner Earnings per Share (TTM) Calculation:

TTM / Last Quarter Average of Last 20 Quarters
Net Income 492
Depreciation, Depletion and Amortization 28
Change In Deferred Tax 69
5Y Average of Maintenance Capital Expenditure 26
Change In Working Capital 120
Shares Outstanding (Diluted Average) 29

1. Start with "Net Income" from income statement. Medpace Holdings's Net Income for the trailing twelve months (TTM) ended in Jun. 2026 was $492 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. Medpace Holdings's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Jun. 2026 was $28 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. Medpace Holdings's Change In Deferred Tax for the trailing twelve months (TTM) ended in Jun. 2026 was $69 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = $26 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous quarter. If the revenue decreased from the previous quarter, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous quarter, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

Medpace Holdings's 5-Year Average Maintenance Capital Expenditure = $26 Mil

5. "Change In Working Capital" is from cashflow statement. Medpace Holdings's Change In Working Capital for the trailing twelve months (TTM) ended in Jun. 2026 was $120 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. Medpace Holdings's Shares Outstanding (Diluted Average) for the months ended in Jun. 2026 was 28.554 Mil.

Medpace Holdings's Onwer Earnings Per Share for Jun. 2026 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( 491.5 +27.796+68.741
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-26.235204184432+120.285)/28.554
=23.89

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=574.985/23.89
=24.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Owner Earnings per Share (TTM) of 23.89 mean?
Medpace Holdings (MEDP) has a Owner Earnings per Share (TTM) of 23.89 as of Jun. 2026. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Medpace Holdings. This is near median its historical median of 23.67. Over the past decade, Medpace Holdings' Owner Earnings per Share (TTM) has ranged from 13.25 to 48.61. According to the industry distribution chart, Medpace Holdings ranks #35 out of 75 companies in the Medical Diagnostics & Research industry, placing it in the top 46.7%.
Is Medpace Holdings' Owner Earnings per Share (TTM) too high?
Medpace Holdings' current Owner Earnings per Share (TTM) of 23.89 is near median its 10-year median of 23.67. Over the past 10 years, this metric has ranged from a low of 13.25 to a high of 48.61. The Medical Diagnostics & Research industry median Owner Earnings per Share (TTM) is 26.46. Medpace Holdings' value of 23.89 is 9.7% below this industry median. Based on the distribution chart, Medpace Holdings ranks #35 out of 75 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Medpace Holdings has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medpace Holdings' Owner Earnings per Share (TTM) compare to GH and ICLR?
According to the Medical Diagnostics & Research industry distribution chart, Medpace Holdings ranks #35 out of 75 companies for Owner Earnings per Share (TTM). This puts Medpace Holdings in the upper half of its industry. The industry median Owner Earnings per Share (TTM) is 26.46. Medpace Holdings' value of 23.89 is 9.7% below this benchmark. Historically, Medpace Holdings' own Owner Earnings per Share (TTM) has ranged from 13.25 to 48.61 over the past decade. While the company's 10-year median is 23.67 vs. the industry median of 26.46, Medpace Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Owner Earnings per Share (TTM) for a Medical Diagnostics & Research company?
The median Owner Earnings per Share (TTM) among Medical Diagnostics & Research companies is 26.46, based on 75 companies in the industry. Companies in the top quartile (top 25%) have a Owner Earnings per Share (TTM) significantly above this median, while those in the bottom quartile fall well below. However, Owner Earnings per Share (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medpace Holdings's current Owner Earnings per Share (TTM) of 23.89 is 9.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Owner Earnings per Share (TTM) mean?
A high Owner Earnings per Share (TTM) can signal that a stock is expensive relative to its fundamentals. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Medpace Holdings. For the Medical Diagnostics & Research industry, the median Owner Earnings per Share (TTM) is 26.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medpace Holdings's current Owner Earnings per Share (TTM) is 23.89, which is near median its own 10-year median of 23.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medpace Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medpace Holdings (MEDP) is currently considered Fairly Valued. The stock's GF Value™ is $531.14, compared to a current price of $574.99 — trading 8.3% above its estimated fair value. The current Owner Earnings per Share (TTM) is 23.89, which is near median its 10-year median of 23.67 and 9.7% below the Medical Diagnostics & Research industry median of 26.46. Medpace Holdings' overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Owner Earnings per Share (TTM) calculated?
Owner Earnings per Share (TTM) is calculated from a company's financial statements. For Medpace Holdings (MEDP), the current Owner Earnings per Share (TTM) is 23.89 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medpace Holdings (MEDP) Overvalued in 2026?

Based on GuruFocus' analysis, Medpace Holdings stock appears to be overvalued. The current stock price of $574.99 is trading 8.3% above its estimated GF Value™ of $531.14. GuruFocus considers Medpace Holdings to be Fairly Valued.

Key valuation signals for MEDP:

  • Owner Earnings per Share (TTM): 23.89 (near median its 10-year median of 23.67)
  • GF Value™: $531.14 vs. price of $574.99 (8.3% above fair value)
  • GF Score™: 97/100 with 2 warning signs
  • Industry Position: 9.7% below the Medical Diagnostics & Research median (#35 of 75)

No single metric tells the full story. See the MEDP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medpace Holdings Business Description

Other Exchanges MEDP:Mexico01P:Germany
Address 5375 Medpace Way, Cincinnati, OH, USA, 45227
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
97GF Score

Get the complete analysis for MEDP

Owner Earnings per Share (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$574.99
Price
$531.14
GF Value